Eastwood Bio Medical Canada Inc (EBM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 45 | 108 | 108 | 107 | 105 |
| Accounts receivable | 28 | -28 | 0 | -9 | 4 |
| Accounts payable and accrued liabilities | -6 | N/A | N/A | 7 | -6 |
| Other Working Capital | 292 | 312 | 418 | 34 | 394 |
| Other Operating Activity | -340 | -407 | -543 | -144 | -613 |
| Operating Cash Flow | $19 | $-15 | $-17 | $-4 | $-116 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | -3 | -6 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-3 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -5 | -5 | 58 | N/A |
| Debt Issued | N/A | N/A | N/A | 0 | 20 |
| Debt Repayment | N/A | N/A | N/A | -32 | N/A |
| Financing Cash Flow | $0 | $-5 | $-5 | $26 | $20 |
| Beginning Cash Position | -1 | 18 | 40 | 21 | 123 |
| End Cash Position | 18 | -1 | 18 | 40 | 21 |
| Net Cash Flow | $19 | $-20 | $-21 | $19 | $-102 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19 | -15 | -17 | -4 | -116 |
| Capital Expenditure | N/A | N/A | N/A | -3 | -6 |
| Free Cash Flow | 19 | -15 | -17 | -7 | -122 |